Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy

Junedh M Amrute1,2,3,4,5, In-Hyuk Jung1,5, Tracy Yamawaki2

  • 1Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.

Science (New York, N.Y.)
|January 29, 2026
PubMed

Insights

Fibroblast activation protein (FAP) marks changing vascular smooth muscle cells in coronary artery disease (CAD). Targeting FAP with immunotherapy offers a new treatment strategy for CAD.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Translational Medicine

Background:

  • Vascular smooth muscle cell (VSMC) diversification is a key driver of atherosclerotic coronary artery disease (CAD).
  • The precise mechanisms controlling VSMC state transitions in CAD remain largely unknown.
  • Understanding these cellular dynamics is crucial for developing effective CAD therapies.

Purpose of the Study:

  • To elucidate the cellular mechanisms underlying VSMC diversification in human CAD.
  • To identify novel cellular markers and therapeutic targets for atherosclerotic disease.
  • To evaluate the potential of targeting identified markers for CAD immunotherapy.

Main Methods:

  • Multiomic single-cell profiling and spatial transcriptomics were performed on 27 human coronary arteries.
  • Epitope mapping and lineage tracing in mouse models were utilized.
  • Positron emission tomography (PET) imaging with FAP tracers was conducted in CAD patients.
  • Development and testing of an anti-FAP bispecific T-cell engager therapy.

Main Results:

  • Fibroblast activation protein (FAP) was identified as a marker for modulated VSMCs in human CAD.
  • FAP-expressing cells were found to originate from Myh11+ VSMCs and reside in the macrophage-rich neo-intima.
  • FAP PET imaging demonstrated significant plaque uptake in CAD patients.
  • Therapeutic intervention with an anti-FAP bispecific T-cell engager reduced atherosclerotic plaque burden and modulated the stromal-immune microenvironment.

Conclusions:

  • This study provides a comprehensive single-cell and spatial atlas of human CAD, revealing key cellular players.
  • FAP is established as a reliable marker for VSMC modulation in the context of atherosclerosis.
  • Targeting FAP via immunotherapy presents a promising lipid-independent therapeutic strategy for CAD.

Related Concept Videos

Functions of Smooth Muscles01:23

Functions of Smooth Muscles

Smooth muscles are an important type of muscle tissue that plays a vital role in the involuntary movements of internal organs. For example, they help regulate the movement of food through the gut and the flow of blood through the circulatory system.
Function of visceral smooth muscles
Visceral smooth muscle is found in the walls of all hollow organs, except the heart, and is a key player in the involuntary movements that drive the functioning of these internal organs. This tissue is arranged in...
3.4K
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
7.7K
Structure and Organization of Smooth Muscles01:13

Structure and Organization of Smooth Muscles

Smooth muscle tissue is a type of muscle tissue that can be found lining various vital organs in the human body, including the lungs, blood vessels, digestive tract, and respiratory tract. This type of tissue is responsible for regulating the movements of these organs, playing crucial roles in the functioning of various systems, including the vascular, digestive, respiratory, and urinary systems.
Structure of smooth muscle cell
Smooth muscle cells are spindle-shaped with tapering ends and a...
8.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
398
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K